Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative

Author:

Simon Michael S.1ORCID,Beebe-Dimmer Jennifer L.1,Hastert Theresa A.1ORCID,Manson JoAnn E.2,Cespedes Feliciano Elizabeth M.3ORCID,Neuhouser Marian L.4,Ho Gloria Y. F.5,Freudenheim Jo L.6,Strickler Howard7ORCID,Ruterbusch Julie1,Barac Ana8,Chlebowski Rowan9ORCID,Caan Bette3

Affiliation:

1. Department of Oncology, Karmanos Cancer Institute; Wayne State University; Detroit Michigan

2. Department of Medicine; Brigham and Women's Hospital and Harvard Medical School; Boston Massachusetts

3. Division of Research; Kaiser Permanente; Oakland California

4. Division of Public Health Sciences; Fred Hutchinson Cancer Research Center; Seattle Washington

5. Department of Occupational Medicine, Epidemiology and Prevention, Feinstein Institute for Medical Research; Hofstra Northwell School of Medicine; Great Neck New York

6. Department of Epidemiology and Environmental Health; University at Buffalo; Buffalo New York

7. Department of Epidemiology and Public Health; Albert Einstein; New York New York

8. MedStar Heart and Vascular Institute; Washington DC

9. Department of Medical Oncology and Therapeutics Research; City of Hope National Medical Center; Duarte California

Funder

National Cancer Institute

National Heart, Lung and Blood program office

National Heart, Lung, and Blood Institute

Cancer Center Support

Blue Cross Blue Shield Foundation of Michigan

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3